Table 1 Body weights and muscle Mass.

From: Evaluation of biological sex on endstage pathobiology and regenerative treatment of volumetric muscle loss

   

Male

Female

  

n

No Repair

Minced Graft

No Repair

Minced Graft

Body Weight

      

Pre-Injury (g)

a

18

343 ± 7

345 ± 9

245 ± 20

243 ± 10

56-Days Post (g)

a

18

423 ± 25

433 ± 19

278 ± 23

286 ± 14

Wt Gain (% Initial)

a, b

18

23.6 ± 6.6

25.5 ± 5.3

13.8 ± 4.6

17.8 ± 7.0

Muscle Mass, g

      

VML – TA

a

17–18

0.697 ± 0.115

0.696 ± 0.130

0.444 ± 0.139

0.531 ± 0.061

Contralateral – TA

a

18

0.858 ± 0.080

0.894 ± 0.061

0.616 ± 0.048

0.628 ± 0.052

VML – EDL

a

17–18

0.194 ± 0.034

0.198 ± 0.049

0.116 ± 0.025

0.131 ± 0.026

Contralateral – EDL

a

18

0.183 ± 0.023

0.190 ± 0.019

0.129 ± 0.016

0.127 ± 0.012

VML: Contralateral – TA

c

17–18

0.812 ± 0.102

0.779 ± 0.135

0.724 ± 0.211

0.844 ± 0.080*

Muscle Mass, g/kg BW

      

VML – TA

 

17–18

1.649 ± 0.263

1.612 ± 0.297

1.604 ± 0.482

1.855 ± 0.201

Contralateral – TA

a

18

2.025 ± 0.137

2.067 ± 0.137

2.228 ± 0.178

2.195 ± 0.161

VML – EDL

 

17–18

0.458 ± 0.081

0.456 ± 0.112

0.419 ± 0.096

0.457 ± 0.093

Contralateral – EDL

 

18

0.430 ± 0.041

0.439 ± 0.037

0.465 ± 0.063

0.443 ± 0.041

VML: Contralateral – TA

 

17–18

0.812 ± 0.102

0.779 ± 0.135

0.724 ± 0.211

0.816 ± 0.144

  1. Data are presented as mean ± SD
  2. Statistical significance (P < 0.05) was determined by two-way ANOVA with Sidak’s post hoc test
  3. a = main effect by biological sex; b = main effect by treatment; c = interaction; *difference between NR and MG within sex
  4. Wt = weight; TA = tibialis anterior; EDL = extensor digitorum longus; BW = body weight; NR = no repair; MG = minced graft